RADICAVA
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 09 Feb 2024)
What this means for you
Registered since 29 Aug 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86863296
- Registration number
- 5277200
- Mark type
- Stylized text
- Filed
- 31 Dec 2015
- Published for opposition
- 07 Jun 2016
- Registered
- 29 Aug 2017
- Attorney of record
- Jeffrey L. Costellia
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of central nervous system diseases; Pharmaceutical preparations for protection against free radicals; Pharmaceutical preparations for removing free radicals from the human bodies; Neuroprotective medicines; Pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS)
Owner
- K.K. BCJ-94, TOKYO, JP
- Mitsubishi Tanabe Pharma Corporation, Osaka-shi, Osaka, JP
- Mitsubishi Tanabe Pharma Corporation, Osaka-shi, Osaka, JP
- Mitsubishi Tanabe Pharma Corporation, Osaka-shi, Osaka, JP
Prosecution history
- 26 Nov 2025 — ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
- 03 Sept 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 09 Feb 2024 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 09 Feb 2024 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 09 Feb 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 22 Aug 2023 — TEAS SECTION 8 & 15 RECEIVED
- 29 Aug 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 29 Aug 2017 — REGISTERED-PRINCIPAL REGISTER
- 27 Jul 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Jul 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Jul 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 22 Jun 2017 — USE AMENDMENT FILED
- 21 Jul 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 22 Jun 2017 — TEAS STATEMENT OF USE RECEIVED
- 27 Jan 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED